All stock lists
Unlock the score
Iambic Therapeutics, Inc. (NASDAQ:IAM)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
14.41+0.15 (+1.05%)
Insider Score
/ 100
IAM Insider Score
Iambic Therapeutics, Inc. has a live Insider Score.
Scored on 1 qualifying trade from 1 insider in the last 90 days.
IAM analyst forecast
No analyst ratings in the last 12 months
No independent sell-side analyst publishes on IAM that our data provider carries. That is normal for smaller listings, and it is not a judgement on the company. Here is what we track instead:
- Insider activity and the Insider Score — what the people who run the company are doing with their own money.
- Promoter Scores — any disclosed paid stock promotion on this ticker.
Best analysts covering IAM
No firm covering IAM has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.